124 related articles for article (PubMed ID: 26353042)
1. Current and novel treatment options for peripheral T-cell lymphoma.
Horwitz SM
Clin Adv Hematol Oncol; 2015 Jul; 13(7):463-6. PubMed ID: 26353042
[No Abstract] [Full Text] [Related]
2. Therapeutic options in peripheral T cell lymphoma.
Zhang Y; Xu W; Liu H; Li J
J Hematol Oncol; 2016 Apr; 9():37. PubMed ID: 27071634
[TBL] [Abstract][Full Text] [Related]
3. Current management of peripheral T-cell lymphomas.
Gooptu M; Rhoades R; Pro B
Cancer Treat Res; 2015; 165():289-303. PubMed ID: 25655615
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
Saillard C; El Cheikh J; Granata A; Coso D; Schiano JM; Bouabdallah R; Blaise D; Charrier N; Broussais F
Leuk Lymphoma; 2016; 57(3):714-6. PubMed ID: 26750740
[No Abstract] [Full Text] [Related]
5. Current treatment and future prospects for peripheral T-cell lymphoma.
Eyre TA; Collins GP
Drugs Today (Barc); 2013 Oct; 49(10):631-46. PubMed ID: 24191256
[TBL] [Abstract][Full Text] [Related]
6. Novel agents in development for peripheral T-cell lymphoma.
O'Connor OA
Semin Hematol; 2010 Apr; 47 Suppl 1():S11-4. PubMed ID: 20359580
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell lymphoma: new therapeutic strategies.
Petrich AM; Rosen ST
Oncology (Williston Park); 2013 Sep; 27(9):878-84. PubMed ID: 24282984
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors: novel agents in cancer treatment.
Glass E; Viale PH
Clin J Oncol Nurs; 2013 Feb; 17(1):34-40. PubMed ID: 23372094
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for peripheral T-cell lymphomas.
Foss FM
Best Pract Res Clin Haematol; 2013 Mar; 26(1):43-56. PubMed ID: 23768640
[TBL] [Abstract][Full Text] [Related]
10. Enhancing existing approaches to peripheral T-cell lymphoma.
Foss FM
Semin Hematol; 2010 Apr; 47 Suppl 1():S8-10. PubMed ID: 20359584
[TBL] [Abstract][Full Text] [Related]
11. Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas.
Watanabe T
Expert Opin Investig Drugs; 2010 Sep; 19(9):1113-27. PubMed ID: 20649502
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-cell lymphoma: time for a T-cell-centric standard of care.
Saint Fleur-Lominy S; Diefenbach CS
Oncology (Williston Park); 2013 Sep; 27(9):885-6. PubMed ID: 24282985
[No Abstract] [Full Text] [Related]
13. Peripheral T-cell lymphoma: what's the role for transplant?
Cohen JB; Flowers CR
Oncology (Williston Park); 2013 Sep; 27(9):891-2. PubMed ID: 24282986
[No Abstract] [Full Text] [Related]
14. The role of high-dose therapy in peripheral T-cell lymphomas.
Reimer P; RĂ¼diger T; Wilhelm M
Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
[TBL] [Abstract][Full Text] [Related]
15. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.
Foss F; Advani R; Duvic M; Hymes KB; Intragumtornchai T; Lekhakula A; Shpilberg O; Lerner A; Belt RJ; Jacobsen ED; Laurent G; Ben-Yehuda D; Beylot-Barry M; Hillen U; Knoblauch P; Bhat G; Chawla S; Allen LF; Pohlman B
Br J Haematol; 2015 Mar; 168(6):811-9. PubMed ID: 25404094
[TBL] [Abstract][Full Text] [Related]
16. T time: Emerging and new therapies for peripheral T-cell lymphoma.
Mina A; Pro B
Blood Rev; 2022 Mar; 52():100889. PubMed ID: 34716031
[TBL] [Abstract][Full Text] [Related]
17. Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Rashidi A; Cashen AF
Future Oncol; 2015; 11(11):1659-64. PubMed ID: 26043217
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors in lymphoma.
Copeland A; Buglio D; Younes A
Curr Opin Oncol; 2010 Sep; 22(5):431-6. PubMed ID: 20683267
[TBL] [Abstract][Full Text] [Related]
19. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
20. [Peripheral T cell lymphoma].
Niitsu N
Gan To Kagaku Ryoho; 2009 May; 36(5):752-5. PubMed ID: 19496284
[No Abstract] [Full Text] [Related]
[Next] [New Search]